Scientific letters

• Clinical association of the SCN5A c.2302A>G variant (p.Ile768Val) with Brugada syndrome

  Boris Kuzmicic Calderón, Bernardita Martínez Galdames, Mario Hassi Thumala, Jorge Van Grieken, Jovan Kuzmicic

  Rev Esp Cardiol. 2025;78:657-9

• Recurrent chronic thromboembolic pulmonary hypertension following balloon pulmonary angioplasty

  Claudio M. Rivadulla Varela, Ignacio Fernández Herrero, Nicolás Maneiro Melón, Fernando Sarnago Cebada, Pilar Escribano Subías, Maite Velázquez Martín

  Rev Esp Cardiol. 2025;78:655-7

• Population-based analysis of the cost of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation

  Zojaina Hernández Rojas, M. Rosa Dalmau Llorca, Carina Aguilar Martín, Elisabet Castro Blanco, Manuel García-Goñi, Josep M. Alegret

  Rev Esp Cardiol. 2025;78:652-5

• Left atrial appendage occlusion in patients with atrial fibrillation and cancer. Short- and mid-term outcomes

  Sergio López-Tejero, Pablo Antúnez-Muiños, Miguel Hernández-Hidalgo, Ana Martín-García, Pedro L. Sánchez-Fernández, Ignacio Cruz-González

  Rev Esp Cardiol. 2025;78:659-62

• Interatrial conduction block as a consequence of wide antral pulmonary vein isolation

  Amaia Martínez León, David Testa Alonso, María Salgado, Minel Soroa, Daniel García-Iglesias, David Calvo

  Rev Esp Cardiol. 2025;78:571-3

• Temporal trends in implantable cardioverter-defibrillator prescription as primary prevention in dilated cardiomyopathy

  Carlos Moliner-Abós, Meritxell Santaló-Corcoy, Javier Meseguer-Donlo, Andrea Crehuet-Llonch, Bieito Campos García, Sònia Mirabet Pérez

  Rev Esp Cardiol. 2025;78:568-71

• Coronary microvascular dysfunction in patients with cancer experiencing angina with nonobstructive coronary arteries

  Ilan Merdler, Abhishek Chaturvedi, Brian C. Case, Hayder D. Hashim, Ron Waksman, Hector M. Garcia-Garcia

  Rev Esp Cardiol. 2025;78:565-8

• Recurrent readmissions for heart failure: a persistent issue even in patients achieving stability

  Fernando Aguilar Rodríguez, Javier de Juan Bagudá, Rafael Salguero Bodes, José Luis Bernal Sobrino, Daniel Ferreiro López, Juan F. Delgado Jiménez

  Rev Esp Cardiol. 2025;78:563-5

• Coronary plaque modification and impact on the microcirculation territory after drug-coated balloon angioplasty: the PLAMI study

  José Antonio Sorolla Romero, Andrea Teira Calderón, Jean Paul Vilchez Tschischke, José Luis Díez Gil, Hector M. Garcia-Garcia, Jorge Sanz Sánchez

  Rev Esp Cardiol. 2025;78:481-2

• Lipoprotein (a) levels and their relationship to other risk factors in patients with atherosclerotic coronary artery disease

  Pablo Toledo-Frías, Aurora Martínez-Ballesta, Jesús G. Sánchez-Ramos, Eduardo Moreno-Escobar

  Rev Esp Cardiol. 2025;78:482-4

• Cardioverter-defibrillator implantation in chronic Chagas cardiomyopathy: the Rassi death risk score for decision-making

  Juan Carlos Carrion-Arias, Christina Grüne de Souza e Silva, Basílio de Bragança Pereira, Emília Matos do Nascimento, Roberto Coury Pedrosa

  Rev Esp Cardiol. 2025;78:485-6

• Interaction between age and therapeutic approach on outcome in older patients with patent foramen ovale-associated stroke

  Seyoung Jung, Byung Joo Sun, Soe Hee Ann, Jong Shin Woo, Jung-Sun Kim, Pil Hyung Lee

  Rev Esp Cardiol. 2025;78:487-8

• Transcatheter pulmonary valve replacement for the treatment of carcinoid heart disease

  Gaspard Suc, Agnes Cachier, Sebastien Hascoet, Dimitri Arangalage, Bernard Iung, Marina Urena

  Rev Esp Cardiol. 2025;78:368-71

• Incidence and chronology of atrioventricular block and outcomes after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy

  Maria Calvo Barceló, Raquel Adeliño, Yassin Belahnech, Pablo Jordán-Marchite, Nuria Rivas-Gándara, Jaume Francisco Pascual

  Rev Esp Cardiol. 2025;78:371-4

• Validation of 2 clinical scores for transthyretin amyloid cardiomyopathy in a Mediterranean cohort of patients at risk

  Mireia Llevadot, Germán Cediel, Mar Domingo, Gloria Moragas, Montserrat Solà, Antoni Bayés-Genís

  Rev Esp Cardiol. 2025;78:374-6

• VE/VCO2 slope and malignant ventricular arrhythmias in heart failure

  Néstor Báez-Ferrer, Daniel Hernández-Vaquero, Pablo Avanzas, Alberto Domínguez-Rodríguez

  Rev Esp Cardiol. 2025;78:376-9

• Prognostic significance of right ventriculoarterial coupling in patients undergoing isolated tricuspid valve surgery

  Marcelo Luque, Isidre Vilacosta, Manuel Carnero, Julián Pérez-Villacastín, Alberto de Agustín, Eduardo Pozo Osinalde

  Rev Esp Cardiol. 2025;78:279-81

• David after Ross: a possible option before Bentall?

  César A. Rodríguez Canedo, Ramón Pérez-Caballero, Carlos A. Pardo Pardo, José F. Gutiérrez Díez, Raquel Prieto-Arevalo, Juan-Miguel Gil-Jaurena

  Rev Esp Cardiol. 2025;78:277-9

• Peripheral access ultrafiltration in adults with complex congenital heart disease and refractory congestion

  Borja Guerrero Cervera, Raquel López-Vilella, Joaquín Rueda Soriano, Víctor Donoso Trenado, Francisco Buendía Fuentes, Luis Almenar Bonet

  Rev Esp Cardiol. 2025;78:274-7

• Lumenless versus stylet-driven leads in left bundle branch pacing

  Álvaro Marco del Castillo, Javier Ramos Jiménez, Luis Borrego Bernabé, Fernando Arribas Ynsaurriaga, Daniel Rodríguez Muñoz, Rafael Salguero Bodes

  Rev Esp Cardiol. 2025;78:272-4